Featured article

U.S. FDA grants Priority Review for Nicox’s AC-170 New Drug Application

21/06/2016

FDA assigns Prescription Drug User Fee Act (PDUFA) goal date of October 18, 2016 ………………………………………………………………………………………….  Sophia Antipolis, France. Nicox S.A. (Euronext Paris: FR0000074130, COX), the international ophthalmic company, today announced […]

[Read more]